• 1. District Three of Department of Colorectal and Anal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, P. R. China;
  • 2. Department of General Surgery, New Rong Qi Hospital, Foshan, Guangdong 528203, P. R. China;
  • 3. Department of Gastrointestinal Endoscopy, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, P. R. China;
WANG Hui, Email: wanghuislh@hotmail.com
Export PDF Favorites Scan Get Citation

Objective This study aimed to discuss the risk factors associated with the delay reversal ileostomy following sphincter-preserving surgery for rectal cancer.Methods Clinical data were collected retrospectively on 130 consecutive patients undergoing defunctioning ileostomy following sphincter-preserving surgery for rectal cancer, between January 2014 and December 2014 in the Sixth Affiliated Hospital of Sun Yat-sen University. According to the reversal time of ileostomy, the patients were divided into two groups, including the delay reversal ileostomy group (≥120 d, n=72) and the normal ileostomy group (<120 d, n=58).Results One hundred and thirty patients were studied (median time to reversal 132 d, range 39–692 d). Logistic regression model showed that adjuvant chemotherapy (OR=14.106, P=0.002), distance of tumor from the anal verge (OR=0.019, P=0.002), and anastomotic leakage (OR=32.440, P=0.001) were significant independent risk factors for delayed reversal. Time to reversal was significantly longer in those patients who had adjuvant chemotherapy, anastomotic leakage, and short distance of tumor from the anal verge.Conclusion Adjuvant chemotherapy, short distance of tumor from the anal verge, and anastomotic leakage are the independent risk factors for delay reversal ileostomy following sphincter-preserving surgery for rectal cancer.

Citation: QIU Suyu, HU Minhui, GUO Wentai, HUANG Rongkang, WANG Hui. Risk factors associated with the delay reversal ileostomy following sphincter-preserving surgery for rectal cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(4): 418-422. doi: 10.7507/1007-9424.201901003 Copy

  • Previous Article

    Long-term efficacy of infliximab combined with seton placement in treatment perianal fistulizing Crohn disease
  • Next Article

    Expressions of PD-L1 and A2aR in colorectal cancer and its clinical significances